Skip to content

Study of medication timing of levocetirizine dihydrochloride in patients with recalcitrant chronic urticaria to anti-histamine drug

Study of medication timing of levocetirizine dihydrochloride in patients with recalcitrant chronic urticaria to anti-histamine drug - Study of medication timing of levocetirizine in patients with recalcitrant chronic urticaria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013777
Enrollment
100
Registered
2014-04-25
Start date
2014-08-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic urticaria

Interventions

levocetirizine 10mg daily before sleep levocetirizine 5mg daily before sleep and levocetirizine 5mg anytime the lesion exacerbate

Sponsors

Department of Dermatology, Kurume University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with recarcitrant chronic urticaria

Exclusion criteria

Exclusion criteria: 1. Patients with acute infectious disease 2. Patients who are treated with ultra-violet therapy or hyposensitization therapy 3. Patients who engaged in dangerous job such as driving a car 4. Patients who were treated with systemic steroids less than 2 weeks prior to the initiation of this study 5. Patients who are pregnant or has possibility to be pregnant, and who are lactating 6. Patients who suffered from grave liver, renal, or heart disease 7. Patients who do not have hypertension, diabetes mellitus, or collagen disease 8. Patients who are considered inappropriate to be enrolled in this study by the doctor

Design outcomes

Primary

MeasureTime frame
degree of pruritus

Secondary

MeasureTime frame
adverse event

Countries

Japan

Contacts

Public ContactYohei Natsuaki

Kurume University School of Medicine Department of Dermatology

natsuaki@med.kurume-u.ac.jp+81-942-31-7571

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026